Romanian Drug Market Grows 12.7% in 12 Months Through Sept - Researcher

The driving force behind the growth were retail sales, which accounted for 86.5% of the total, the survey showed.

Hoffmann La Roche led the market with a 7.0% share, followed by French Sanofi-Aventis with 6.9%. British GSK and Swiss Novartis ranked third, each with a share of 6.8% of the Romanian market in the period under review. Local drug maker Terapia Ranbaxy had a 4.6% market share, Zentiva S.A. held 3.9% of the market, while Antibiotice controlled 2.8%.

Romania's pharmaceuticals market is seen growing by 7.9% this year, Cegedim said.

(1 euro = 3.8419 Romanian lei)